Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group

  1. del Alcázar, E.
  2. Suárez-Pérez, J.A.
  3. Armesto, S.
  4. Rivera, R.
  5. Herrera-Acosta, E.
  6. Herranz, P.
  7. Martín, I.
  8. Montesinos, E.
  9. Hospital, M.
  10. Vilarrasa, E.
  11. Ferran, M.
  12. Ruiz-Villaverde, R.
  13. Sahuquillo-Torralba, A.
  14. Ruiz-Genao, D.P.
  15. Pérez-Barrio, S.
  16. Muñoz, C.
  17. Llamas, M.
  18. Valentí, F.
  19. Mitxelena, M.J.
  20. López-Ferrer, A.
  21. Carretero, G.
  22. Vidal, D.
  23. Mollet, J.
  24. Belinchón, I.
  25. Carrascosa, J.M.
Aldizkaria:
Journal of the European Academy of Dermatology and Venereology

ISSN: 1468-3083 0926-9959

Argitalpen urtea: 2020

Alea: 34

Zenbakia: 12

Orrialdeak: 2821-2829

Mota: Artikulua

DOI: 10.1111/JDV.16439 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak